Summary
In this blogpost I look at what the most recent LeDeR report
tells us about the deaths of people with learning disabilities before the
COVID-19 pandemic, and what we can learn to support people as the pandemic
continues.
Here is the list of suggested actions coming out of the
blogpost:
We need a much better way of tracking infection rates as
well as deaths amongst people with learning disabilities and those supporting
them, and universal testing.
Flu vaccinations (for people with learning disabilities and
those people supporting them) are crucial, including clear messages throughout
health services that people are eligible for free vaccinations, pro-active strategies
for making sure people are offered them in ways that people are likely to
accept, and support for people to have them.
In
2018/19 only 44% of eligible people with learning disabilities in England had a
flu jab, virtually the same percentage as in 2017/18.
Annual health checks for people with learning disabilities
need to take place urgently, and need to include a specific section on
priorities for keeping people safe during the potential second spike. This
should include urgent medication reviews.
In
2018/19 only 56.1 of eligible people with learning disabilities had an annual
check, a slight increase from 55.1% of people in 2017/18 but far short of
the 75% target set by NHSEI (and way short of the 100% people that is
presumably the ultimate aim?).
NHS to identify and prioritise as a COVID-19 priority those
health services that are particularly important to preserve the health of people
with learning disabilities through any second spike.
Triaging for intensive care treatment for COVID-19 on the
basis of ‘frailty’ should be scrapped.
In advance of a second COVID-19 peak, it should be an urgent
priority to go through proper consultation processes with people and those supporting
them to reach individual decisions on DNACPRs.
Rigorous medication reviews are urgent.
Supporting the health of people with learning disabilities
who are part of BAME groups needs to be a particular priority.
Supporting the health of people with profound and multiple
learning disabilities needs to be a particular priority.
People with epilepsy, dysphagia, constipation and GORD need
to be considered as being at potentially greater risk, and urgent measures to
support people with these conditions is needed.
All these measures should not be targeted at older people
with learning disabilities but are equally important for people at all ages.
As many people as possible need to leave inpatient services
now, even if for medium-term creative alternatives that put people at a lower
risk of COVID-19 infection.
All these measures should be part of a national management
and operational plan set up now and operating through the course of the
pandemic, with substantial direction from people with learning disabilities and
those supporting them (
see
this example from Australia for people with disability).
What this blogpost is
about
In this blogpost I want to talk about the most recent report
from the LeDeR programme, a voluntary programme for the notification and review
of the deaths of people with learning disabilities.
The report
has been published in July 2020, but is called the 2019 report because it
provides information up to the end of 2019. I have written about previous LeDeR
reports
here
and
here,
and about the Government response to a LeDeR report two years ago
here.
To be honest the overall picture has remained depressingly similar over time,
although more detailed analysis is added to the reports every year as more
information becomes available.
In this post I want to talk about what the information from
this report, obviously about a pre-COVID-19 world, can tell us about preventing
even more people with learning disabilities dying as the COVID-19 pandemic
continues.
We already know (largely thanks to
LeDeR
programme notification data, reluctantly released and skeletally analysed
by NHS England/Improvement (NHSEI)) that people with learning disabilities in
England have been dying in disproportionately large numbers in the first wave
of COVID-19. While this may be abeyance at the time of writing (17
th
July 2020), the need to do radically better, urgently, is acute well before
winter comes.
Before going into what the LeDeR report shows, it’s
important to realise there are three main sources of information used in the
report.
1) Notifications.
Anyone can notify a
death of someone with learning disabilities in England to the LeDeR programme
through an online form or ringing the LeDeR team (notifications are what are
being reported weekly during the COVID-19 pandemic). The LeDeR programme has
taken time to become national in its reach (and it’s important to remember that
notifications are not mandatory), so 2019 is probably the first year to produce
truly national figures for England. In 2019 notifications of deaths were made
for 3,060 people in England, up from notifications of 2,720 people’s deaths in
2018 and notifications of 1,265 people’s deaths in 2017.
2) Reviews. The main purpose of the LeDeR programme is to
co-ordinate, stimulate and collate information from reviews of all deaths of
people with learning disabilities notified to LeDeR. These reviews are supposed
to be done by local teams to embed learning from the reviews into local
practice. If there are sufficient concerns identified locally about a person’s
death, this can go forward for a full multi-agency review. Across the whole
time the LeDeR programme has been operating only 45% of notified deaths have
been reviewed. While the proportion of notified deaths being reviewed has
increased over time, even in 2019 only just over two-thirds of notified deaths
were reviewed (69.5% review rate in 2019, compared to 33.6% in 2018 and 9.1% in
2017), so reviews are still not keeping pace with notified deaths let alone
catching up with the backlog.
3) For notified deaths, information on causes of death can
be obtained from death certificates via the Office for National Statistics
(ONS). The LeDeR programme has obtained these for the deaths of 84% of people
since the programme started up to the end of 2019.
How many people are
dying during the pandemic compared to before?
Bearing these different sources of information in mind, what
can we learn from the LeDeR programme in 2019 to help understand what’s
happening to people with learning disabilities during the pandemic? The first
thing is that we now have information on how many people died in 2019 against
which to compare how many people have died so far in 2020. The graph below sets
this out, but it’s quite complicated so I’ll go through it. The columns show
how many people’s deaths have been notified to the LeDeR programme so far in
2020. The red parts of the column are people who have been notified to LeDeR as
dying of confirmed or suspected COVID-19, the blue parts of the column are
people recorded as dying of a non-COVID-19 cause. The biggest column on the
left is all deaths from 1st January 2020 to 20th March
2020 (around 11 weeks) – after that each column shows the number of people’s
deaths each week up to the week ending 10th July 2020.
The red columns show a sharp rise in the number of people with
learning disabilities dying a COVID-19 related death up to a peak in early-mid
April (the same time as the peak for people generally in England), and then a
reduction to the point that for the past month fewer than 5 people per week
have been notified to LeDeR as dying of COVID-19. The blue columns show that,
at the same time as the COVID-19 peak, more people were also notified to LeDeR
as dying of other causes – this has gradually reduced to around 35 people per
week dying non-COVID-19 deaths in the past month.
How does this compare to the number of people with learning disabilities
dying in 2019, before COVID-19? The very dark blue line on the graph shows the
average number of people dying per week notified to LeDeR in 2019 – this was
3,060 people’s deaths, or 58.9 deaths of people with learning disabilities
every week [this is close to the 54 people dying per week from 2016-2019 I
shonkily calculated from other statistics in a previous blog, so there is some
consistency there]. The LeDeR report shows there is some seasonal variation in
how many people’s deaths were notified to them in 2019 (highest October –
December) but the variation is not so extreme as to make a big difference to
the figures for January – July. The
striking thing about this line for me is how many more people’s deaths were
notified to LeDeR in the very early part of 2019 compared to the very early
part of 2020 (before COVID-19 really hit the UK). At the peak of the pandemic,
the number of non-COVID deaths notified to LeDeR was similar to the average
weekly level for 2019 (and dropping to well below these levels by June), with
additional COVID-19 deaths during the peak. I don’t know why this is, but it
does suggest that before the COVID-19 pandemic really hit many fewer people’s
deaths were being notified to the LeDeR programme than in 2019 – perhaps the
NHS gearing up for COVID-19 (including the suspension of LeDeR reviews) was
partly responsible? This means that the LeDeR figures for 2020 might seriously
under-estimate the number of people with learning disabilities dying in 2020.
Finally, as the LeDeR report makes grimly clear, before the
COVID-19 pandemic people with learning disabilities (as has been the case for a
long time) were twice as likely to die deaths that were avoidable than the
general population, with approaching half of people with learning disabilities
(44% vs 22% for the general population) dying an avoidable death (avoidable
deaths are the total of deaths that were preventable, treatable, or both). The
final, dark green line on the graph shows how many people with learning
disabilities in 2019 would have died if the level of avoidable deaths was the
same as for the general population (using age-standardised mortality rates). Even
before the pandemic, LeDeR reports that 19% of people with learning
disabilities compared to 14% of the general population died in ways that were
preventable (where better public health or ways to stop people becoming
unhealthy in the first place, such as preventing obesity or smoking, would have prevented the person's death).
Particularly grim was the finding that one-third of people with learning
disabilities (34%) died in ways that were treatable (timely and effective
healthcare, or effective interventions to reverse ill-health, would have prevented the person's death) compared to 8% of
the general population.
Throughout the first wave of COVID-19, this already poor
treatment on the part of health services is likely to have got worse for many
people with learning disabilities, as intensive care services were prioritised
partly by the withdrawal or reduction of health services of particular
relevance to people with learning disabilities. This is likely to be placing people at
greater risk of having a severe reaction to COVID-19. This includes postural
care and wheelchair support services, annual health checks and a range of primary
care services, and speech and language therapy (in this context, particularly
important for people with dysphagia). In any preparation for a future COVID-19
spike, it is crucial now to identify and include as a COVID-19 priority those
health services that are particularly helpful (in both the short and long term)
in helping people with learning disabilities reduce their COVID-19 risk.
Who is dying?
One of my extreme frustrations throughout the COVID-19
pandemic has been the lack of published analysis of what puts people with
learning disabilities at greater risk of dying from COVID-19, despite relevant information
being present in the datasets being used. Public Health England are apparently
due to publish a much more complete analysis of the figures relating to people with
learning disabilities during COVID-19 by the end of July 2020.
The LeDeR report gives us a picture from before COVID-19 (2017-2019)
of who amongst people with learning disabilities was at greater risk of dying.
Most obviously, on average people with learning disabilities
died at much younger ages than the general population. The median age at death
(the age at which half the group have died younger and half the group have died
older) was 61 years for boys/men with learning disabilities in 2019 (vs 83
years in the general population), and 59 years for girls/women with learning disabilities
(vs 86 years in the general population). The graph below shows the percentage
of people with learning disabilities vs the general population who died by the
age at which they died. As the graph shows, 85% of the general population die
at the age of 65 years or older, compared to 37% of people with learning
disabilities.
COVID-19 analysis so far has shown that older age is the
biggest risk factor for dying from COVID-19; within the broad older age
category, increasing age means increasing risk. Data from adults with learning
disabilities and/or autistic people in particular types of registered social
care, produced by the Care Quality Commission, reported that 47% of people who
died between 10 April and 15 May 2019 were aged 65 years or older, compared to
44% of people who died of non-COVID causes in the same time period in 2020 and
45% of people who died of COVID-19 in the same time period in 2020 (the
timeframe starts in the middle of the first COVID-19 peak). This suggests that,
amongst people with learning disabilities, COVID-19 does not seem to be
disproportionately affecting older people compared to other causes. This could
be for any number of reasons:
2) people with learning disabilities are more likely to
experience multiple health conditions that may put people at risk of a severe
reaction to COVID-19 at a younger age than the general population.
In the general population, being part of a Black or Minority
Ethnic (BAME) group has been associated with a higher risk of death from
COVID-19. The LeDeR report shows that, even before the pandemic, people with
learning disabilities from BAME communities (and particularly those people with
profound and multiple learning disabilities) were more likely to die at much
younger ages than White British people with mild/moderate learning
disabilities. These inequalities pre-COVID are illustrated in the LeDeR by
looking at median age of death. If you are a person with mild/moderate learning
disabilities (to sue the report’s terminology), if you are White British your
median age at death is 64 years compared to 54 years if you are part of a BAME
group. If you are a person with severe or profound and multiple learning
disabilities, if you are White British your median age at death is 57 years
compared to only 31 years if you are part of a BAME group.
Given how COVID-19 has disproportionately affected people in
BAME communities generally, it is possibly that COVID-19 might be worsening
these already existing inequalities in the deaths of people with learning
disabilities.
It is also clear that support for people with profound and
multiple learning disabilities should be particularly important during any
second COVID-19 spike.
Where do people die?
Again, there is an absence of information about where people
with learning disabilities are dying during the COVID-19 pandemic, and where
people were living before they died.
The LeDeR report states that, of those people’s deaths
reviewed in 2019, 60% of people with learning disabilities died in hospital
(compared to 46% of the general population. We don’t know how many people with
learning disabilities who died of COVID-19 died in hospital compared to other
places. A simplistic comparison of the number of confirmed COVID-19 deaths of
people with learning disabilities and/or autistic people in hospital reported
by NHS England (516 people to date) vs the number of COVID-19 deaths of people
with learning disabilities in any location reported by the LeDeR programme in
2020 (640 people to date) would suggest that 81% of people with learning
disabilities dying of COVID-19 died in hospital. This might be another reason
to suspect under-reporting of deaths to the LeDeR programme in 2020 compared to
2019.
One specific issue is about people with learning
disabilities and autistic people dying in inpatient units throughout the
COVID-19 pandemic. The LeDeR report states that 9 people either in inpatient
units or discharged from one less than 2 months previously had died in 2019 –
the
latest figures from the MHSDS report that 10 people with learning
disabilities and/or autistic people had died in inpatient units in one month
(April 2020, the peak of the pandemic).
Do not resuscitate
orders (DNACPRs)
What health
conditions do people die of?
As a population, people with learning disabilities at
younger ages are more likely than the general population to have a wide range
of health conditions associated in the general population with a higher risk of
a severe reaction to COVID-19, such as: chronic obstructive pulmonary disease, high
blood pressure, chronic heart disease, heart failure, stroke, Type 1 and Type 2
diabetes and chronic kidney disease. People with learning disabilities are also
more likely to be extremely overweight starting at younger ages than the
general population.
I
went through the evidence in some detail in this blogpost in March so I won’t
repeat it here.
What I want to highlight in this blogpost is what the LeDeR
report shows about long-term health conditions commonly experienced by people with
learning disabilities but not generally mentioned as risk factors for a severe
reaction to COVID-19 in the general population, perhaps because some of them
are relatively rare in the general population. In particular, pre-COVID-19 the
LeDeR report found that, amongst those who had died, 36% of people had
experienced epilepsy, 29% of people had experienced dysphagia, and 23% of
people had experienced constipation. These three health conditions (along with
Gastro-Intestinal Reflux Disorder, or GORD) are all likely to place people at
greater risk of a severe reaction to COVID-19 and need particular attention.
Prescribed drugs
The LeDeR report pre-COVID-19 reports how common prescribed drugs
were, and how many different drugs people were prescribed, amongst people whose
deaths had been reviewed in 2019. Pretty much everyone who had died (97% of
people) had been prescribed at least one drug, with 61% of people prescribed 5
or more different drugs (a common definition of ‘polypharmacy’), which is
higher than the level of polypharmacy reported in research studies. For 12% of
people, their combination of drugs could lead to potentially ‘severe’ drug-drug
interactions affecting health and life, and for a further 14% of people their
combination of drugs could lead to potentially ‘moderate’ drug-drug
interactions causing pain and discomfort.
The most commonly prescribed drugs relate to health
conditions relevant to COVID-19, as I’ve mentioned above.
Over 4 out of 10 people (42%) had been prescribed proton pump
inhibitors, presumably for acid reflux. A third of people (33%) had been
prescribed laxatives,
even though
they are not particularly effective. A fifth of people (20%) had been prescribed
hypertensives and treatments for heart failure, and a fifth of people (20%) had
been prescribed lipid regulating drugs.
Many people were prescribed ‘psychotropic’ drugs, affecting
the brain, mood or behaviour. Over a third of people (37%) had been prescribed
anti-epileptics, over a quarter of people (27%) had been prescribed
anti-depressants and just under a quarter of people (23%) had been prescribed
anti-psychotics.
Overall, this paints a really bleak picture for me. For some
health conditions (like high blood pressure) it looks like many people with a health
condition are not being prescribed drugs which could help. More commonly, it
looks like people are being prescribed unnecessary drugs that are ineffective
(like laxatives), have serious side effects (like antipsychotics), and would
not be prescribed if people were supporting to live fulfilling lives. In a
COVID-19 context, these drugs, individually and in combination, may be acting
to increase the chances of a severe reaction to COVID-19. Medication reviews
are needed urgently. And ideas for keeping people ‘safe’ should no be at the
expense of supporting people to lead fulfilling lives, which is likely to be
more protective than a whole heap of the medications people are currently
prescribed.
What to do?
Looking at the LeDeR report for 2019 against what we know
about COVID-19 so far, there are some obvious things that health services
should be doing NOW to get better prepared for a second COVID-19 spike.
We need a much better way of tracking infection rates as
well as deaths amongst people with learning disabilities and those supporting
them, and universal testing.
Flu vaccinations (for people with learning disabilities and
those people supporting them) are crucial, including clear messages throughout
health services that people are eligible for free vaccinations, pro-active strategies
for making sure people are offered them in ways that people are likely to
accept, and support for people to have them.
In
2018/19 only 44% of eligible people with learning disabilities in England had a
flu jab, virtually the same percentage as in 2017/18.
Annual health checks for people with learning disabilities
need to take place urgently, and need to include a specific section on
priorities for keeping people safe during the potential second spike. This
should include urgent medication reviews.
In
2018/19 only 56.1 of eligible people with learning disabilities had an annual
check, a slight increase from 55.1% of people in 2017/18 but far short of
the 75% target set by NHSEI (and way short of the 100% people that is
presumably the ultimate aim?).
NHS to identify and prioritise as a COVID-19 priority those
health services that are particularly important to preserve the health of people
with learning disabilities through any second spike.
Triaging for intensive care treatment for COVID-19 on the
basis of ‘frailty’ should be scrapped.
In advance of a second COVID-19 spike, it should be an urgent
priority to go through proper consultation processes with people and those supporting
them to reach individual decisions on DNACPRs.
Rigorous medication reviews are urgent.
Supporting the health of people with learning disabilities
who are part of BAME groups needs to be a particular priority.
Supporting the health of people with profound and multiple
learning disabilities needs to be a particular priority.
People with epilepsy, dysphagia, constipation and GORD need
to be considered as being at potentially greater risk, and urgent measures to
support people with these conditions is needed.
All these measures should not be targeted at older people
with learning disabilities but are equally important for people at all ages.
As many people as possible need to leave inpatient services
now, even if for medium-term creative alternatives that put people at a lower
risk of COVID-19 infection.
All these measures should be part of a national management
and operational plan set up now and operating through the course of the
pandemic, with substantial direction from people with learning disabilities and
those supporting them (
see
this example from Australia for people with disability).